Aptissen SA

Aptissen SA

Biotechnologieforschung

Plan-les-Ouates, Genève 3.079 Follower:innen

Aptissen delivers orthobiologic solutions to joint medical specialists.

Info

Aptissen S.A. is a Swiss company specialized in the development and commercialization of biopolymer-based medical devices. Aptissen’s founders have developed for the past 25 years the best quality injectable products which meet both patients and doctors expectations: www.aptissen.com The company was founded in 2013 as a spin-off of ANTEIS, and is based in Geneva area, Switzerland. It today distributes its products through a worldwide international distributors' network among more than 90 countries including Europe, South America, Canada, Middle East and Asia. Aptissen's team revolutionized the viscosupplement market with Synolis VA and his patented formulation which combines Hyaluronic Acid and Sorbitol. Synolis VA provides rapid mobility recovery, fast long lasting pain relief associated with excellent safety: www.synolis.com We place the patient benefit at the center of our mission to develop innovative injectable solutions based on hyaluronic acid to provide fast pain relief.

Branche
Biotechnologieforschung
Größe
11–50 Beschäftigte
Hauptsitz
Plan-les-Ouates, Genève
Art
Privatunternehmen
Gegründet
2013
Spezialgebiete
Osteoarthritis, Orthopaedic, Rheumatology, Joint pain, Viscosupplement, Hyaluronic Acid und Injectable

Orte

  • Primär

    Chemin de Champ des Filles 36 A

    Plan-les-Ouates, Genève 1228, CH

    Wegbeschreibung

Beschäftigte von Aptissen SA

Updates

Ähnliche Seiten

Finanzierung

Aptissen SA Insgesamt 1 Finanzierungsrunde

Letzte Runde

Seed

Investor:innen

FONGIT
Weitere Informationen auf Crunchbase